• <SPAN style="font-size: 11.0pt; font-family: 'Arial',sans-serif;">Chimeric Antigen Receptor T Cell with an Inducible Caspase 9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting</SPAN>
• 15-Gene Expression Profile and PRAME as Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1)
• A phase Ib randomized multicenter trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab for uveal melanoma metastases (SCANDIUM II trial)
• Adverse events associated with chimeric antigen receptor T-cell therapy in ophthalmology: a narrative review
• ASO Visual Abstract: Efficacy and Safety of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter, Phase 3 Study
• Association Between Uveal Melanoma and Allostatic Load
• Automated segmentation for early detection of uveal melanoma
• Bilateral Uveal Melanoma: An Insight into Genetic Predisposition in Four New Unrelated Patients and Review of Published Cases
• Biological characteristics and clinical management of uveal and conjunctival melanoma
• Chimeric Antigen Receptor T Cell with an Inducible Caspase 9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting
• Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting
• Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma
• Clinical Characteristics and Special Considerations in the Management of Rare Melanoma Subtypes
• Co-delivery Nano System of MS-275 and V-9302 Induces Pyroptosis and Enhances Anti-Tumor Immunity Against Uveal Melanoma
• Colour fusion effect on deep learning classification of uveal melanoma
• Comparative Single Vesicle Analysis of Aqueous Humor Extracellular Vesicles before and after Radiation in Uveal Melanoma Eyes
• Comparison of stereotactic radiotherapy and protons for uveal melanoma patients
• Comprehensive clinical imaging, histopathological analysis and liquid biopsy-based surveillance of human uveal melanoma in a prolonged rabbit xenograft model
• COMPREHENSIVE MOLECULAR PROFILING OF UVEAL MELANOMA EVALUATED WITH GENE EXPRESSION PROFILING, PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA EXPRESSION, AND NEXT-GENERATION SEQUENCING
• Condensation domain editing of the FR900359 assembly line yields a novel analog amenable to late-stage functionalization
• Correction: Development of a prognostic risk model of uveal melanoma based on N7-methylguanosine-related regulators
• Correction: Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study
• Correlation Analysis of Apparent Diffusion Coefficient Histogram Parameters and Clinicopathologic Features for Prognosis Prediction in Uveal Melanoma
• Corrigendum: Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma
• Death associated protein like 1 acts as a novel tumor suppressor in melanoma by increasing the stability of P21 protein
• Delineating three-dimensional behavior of uveal melanoma cells under anchorage independent or dependent conditions
• Detection of human papillomavirus (HPV) in malignant melanoma
• Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
• Development of a prognostic risk model of uveal melanoma based on N7-methylguanosine-related regulators
• Do Short Delays in Treatment Affect Uveal Melanoma Prognosis?
• Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis
• Electroporation with Calcium or Bleomycin: First Application in an In Vivo Uveal Melanoma Patient-Derived Xenograft Model
• Enhancing the utility of chromosome 6 and 8 testing in uveal melanoma biopsies
• Epigenetic markers of choroidal melanoma
• Erdafitinib promotes ferroptosis in human uveal melanoma by inducing ferritinophagy and lysosome biogenesis via modulating the FGFR1/mTORC1/TFEB signaling axis
• Exploring of miR-155-5p, miR-181b-5p, and miR-454-3p Expressions in Circulating Cell-Free RNA: Insights from Peripheral Blood of Uveal Malignant Melanoma Patients
• Extended survival in a case of metastatic choroidal melanoma with immunotherapy
• External Beam Radiotherapy in the Management of Uveal Melanoma
• Frequency of HLA-A*02:01 in the Brazilian population and its impact on uveal melanoma systemic treatment
• Genome-Wide Methylation Patterns in Primary Uveal Melanoma: Development of MethylSig-UM, an Epigenomic Prognostic Signature to Improve Patient Stratification
• Geometrical accuracy of magnetic resonance imaging for ocular proton therapy planning
• GP100 expression is variable in intensity in melanoma
• Health disparities in ocular oncology
• Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion (PHP) as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma
• Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma
• Impact of Driver Mutations on Metastasis-Free Survival in Uveal Melanoma: A Meta-Analysis
• Impact of the SARS-CoV-2 (COVID-19) Pandemic on Characteristics and Management of Uveal Melanoma in the National Referral Center in Poland
• In vitro and in vivo studies of ocular topically administered NLC for the treatment of uveal melanoma
• Intralesional and Infusional Updates for Metastatic Melanoma
• Iodine Plaque Brachytherapy a Customized Conservative Approach to the Management of Medium/Large-sized Uveal Melanoma
• Iris melanoma in an Australian cohort
• Isolated conjunctival cavernous hemangioma: a rare case report
• Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
• Multiple neoplasms in patients with uveal melanoma: a systematic review
• Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
• Pan‑cancer analysis on the role of KMT2C expression in tumor progression and immunotherapy
• Personalized treatment approaches in intraocular cancer
• Prediction of molecular subclasses of uveal melanoma by deep learning using routine haematoxylin-eosin-stained tissue slides
• Prognostic factors for surgical treatment of radiation-induced scleral necrosis after brachytherapy for uveal melanoma
• Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma
• Programmed Cell Death-Related Gene Signature Associated with Prognosis and Immune Infiltration and the Roles of HMOX1 in the Proliferation and Apoptosis were Investigated in Uveal Melanoma
• Protein and mRNA Expression in Uveal Melanoma Cell Lines Are Related to GNA and BAP1 Mutation Status
• PTCOG Ocular Statement: Expert Summary of Current Practices and Future Developments in Ocular Proton Therapy
• Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition
• Radiation and systemic immunotherapy for metastatic uveal melanoma: a clinical retrospective review
• Radiation-Induced Acquired Lacrimal Drainage Obstructions: Management and Outcomes
• Radiation-Induced DNA Damage in Uveal Melanoma Is Influenced by Dose Delivery and Chromosome 3 Status
• RBMS1 reflects a distinct microenvironment and promotes tumor progression in ocular melanoma
• Re-treatment of locally recurrent uveal melanoma with repeat eye plaque I-125 brachytherapy: A single institution experience
• Re: Stalhammar G: Delays between uveal melanoma diagnosis and treatment increase the risk of metastatic death (Ophthalmology. 2023 Nov 21:S0161-6420(23)00856-4. doi: 10.1016/j.ophtha.2023.11.021. Online ahead of print)
• Re: Stalhammar G: Delays between uveal melanoma diagnosis and treatment increase the risk of metastatic death (Ophthalmology. 2024;131:1094-1104)
• Recent Advances in Molecular and Genetic Research on Uveal Melanoma
• Reporting tumor genomic test results to SEER registries via linkages
• Self-Shielding Gyroscopic Radiosurgery for Uveal Melanoma: A First Case Report
• Senescent endothelial cells promote liver metastasis of uveal melanoma in single-cell resolution
• Shear-wave elastographic imaging in choroidal melanomas: clinical and hemodynamic correlations
• Single cell RNA-sequencing in uveal melanoma: advances in heterogeneity, tumor microenvironment and immunotherapy
• Single-cell hdWGCNA reveals metastatic protective macrophages and development of deep learning model in uveal melanoma
• Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress
• Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation
• Tailoring surveillance imaging in uveal melanoma based on individual metastatic risk
• Tebentafusp (Kimmtrak) for uveal melanoma
• The Chick Chorioallantoic Membrane as a Xenograft Model for the Quantitative Analysis of Uveal Melanoma Metastasis in Multiple Organs
• The Current State of Systemic Therapy of Metastatic Uveal Melanoma
• The elusive BAP1 mutation in pediatric melanocytic tumors
• The Fight Tumour Blindness (FTB!) Registry: Efficient capture of high-quality real-world data in uveal melanoma
• The Fight Tumour Blindness Registry: Efficient capture of high-quality real-world data in uveal melanoma
• The importance of ultrasound-guided biopsy: lesson from a case of liver metastasis from uveal melanoma
• Transcriptomic Analysis of Metastatic Uveal Melanoma and Differences in Male and Female Patients
• TRP channel-related LncRNAs, AC092535.4 and LINC01637, as novel prognostic biomarkers for uveal melanoma
• Tumor Control Probability and Time-Dose Response Modeling for Stereotactic Radiosurgery of Uveal Melanoma
• Tumor Control Probability and Time-Dose-Response Modeling for Stereotactic Radiosurgery of Uveal Melanoma
• Ultrasensitive detection of uveal melanoma using [(18)F]AlF-NOTA-PRGD2 PET imaging
• Using Deep Learning to Distinguish Highly Malignant Uveal Melanoma from Benign Choroidal Nevi
• Using Electronic Health Record Data to Determine the Safety of Aqueous Humor Liquid Biopsies for Molecular Analyses
• Uveal melanoma distant metastasis prediction system: A retrospective observational study based on machine learning
• Uveal Melanoma Zebrafish Xenograft Models Illustrate the Mutation Status-Dependent Effect of Compound Synergism or Antagonism
• Visual Outcomes after Proton Therapy for Recurrent Uveal Melanoma
• Vogt-Koyanagi-Harada-like Syndrome after Cadonilimab (PD-1/CTLA-4 Inhibition) for Metastatic Uveal Melanoma
• Wolfram-silicone implants as effective radiation shielding for ocular brachytherapy: dosimetric features and in vivo animal study on biocompatibility